Neuroprotection in ischaemic stroke commonly means a treatment that results in the preservation of brain tissue in the setting of either focal or global ischaemia. The nominal focus on neuronal tissue ...

Stroke patients with a cerebral vessel occlusion that is clearly visible on brain imaging are potential candidates for intra-arterial thrombolysis. Preliminary evidence indicates that the NIH Stroke ...

DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute ...

Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven ...

The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...

Background and objective: The 24-h National Institutes of Health Stroke Scale (NIHSS) is a promising early surrogate for 90-day functional outcome after mechanical thrombectomy (MT). However, its ...

Mobile stroke units (MSU) enable rapid identification and treatment of thrombolytic-eligible patients with acute ischemic stroke (AIS). Recent studies have highlighted the benefit of MSUs over ...

Objective: This meta-analysis aimed to assess the effectiveness of respiratory muscle training (RMT) in restoring diaphragm function after a stroke. Conclusion: Respiratory muscle training can enhance ...